# Olivier Rascol

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/olivier-rascol/

## Facts

| Field | Value |
| --- | --- |
| Citations | 54,526 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 111 |
| i10-index | 400 |
| Last Known Institution | Université Toulouse III - Paul Sabatier |
| OpenAlex ID | https://openalex.org/A5054027214 |
| ORCID iD | https://orcid.org/0000-0002-1410-6397 |
| Works | 727 |

## Researcher papers

- [Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results](https://scholariq.org/papers/movement-disorder-society-sponsored-revision-of-the-unified-parkinson-s-disease/)
- [The natural history of multiple system atrophy: a prospective European cohort study](https://scholariq.org/papers/the-natural-history-of-multiple-system-atrophy-a-prospective-european-cohort/)
- [Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial](https://scholariq.org/papers/long-term-safety-and-tolerability-of-prosavin-a-lentiviral-vector-based-gene/)
- [Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature](https://scholariq.org/papers/magnetic-resonance-imaging-markers-of-parkinson-s-disease-nigrostriatal/)
- [Summary of the recommendations of the <scp>EFNS</scp>/<scp>MDS</scp>‐<scp>ES</scp> review on therapeutic management of <scp>P</scp>arkinson's disease](https://scholariq.org/papers/summary-of-the-recommendations-of-the-scp-efns-scp-scp-mds-scp-scp-es-scp-review/)
- [Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial](https://scholariq.org/papers/behavioural-outcomes-of-subthalamic-stimulation-and-medical-therapy-versus/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Botulinum Toxin and Related Neurological Disorders](https://scholariq.org/topics/botulinum-toxin-and-related-neurological-disorders/)
- [Parkinson's Disease and Spinal Disorders](https://scholariq.org/topics/parkinson-s-disease-and-spinal-disorders/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)

## Researcher university

- [Université Toulouse III - Paul Sabatier](https://scholariq.org/institutions/universite-toulouse-iii-paul-sabatier/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.